PMID: 1200661Dec 11, 1975Paper

Treatment of mycosis fungoides with topical nitrosourea compounds: Further studies

Archives of Dermatology
H S Zackheim, E H Epstein

Abstract

Twenty-six patients with mycosis fungoides were treated topically with three nitrosourea compounds: carmustine (BCNU), lomustine (CCNU), and 1-methyl-1-nitrosourea. A high percentage experienced good to excellent results. Remissions following treatment of individual lesions varied from one month to at least three years. Remissions following total body surface treatment varied from two weeks to at least four months. Two of 13 patients treated over the entire body suffered temporary bone marrow depression, indluding one with severe pancytopenia. This toxic effect was attributed to lomustine and was not seen in patients treated with carmustine alone. Thirteen patients highly allergic to mechlorethamine hydrochloride showed no cross-sensitivity to nitrosourea compounds. A primary irritant dermatitis occurred in about one half of the patients and telangiectasia in two. Two patients developed hypersensitivity to nitrosourea compounds. Carmustine is the preferred nitrosourea compound for topical therapy of mycosis fungoides.

Citations

Nov 1, 1977·The British Journal of Dermatology·N M PriceE M Farber
Jul 1, 1977·The British Journal of Dermatology·H S ZackheimH I Maibach
Dec 1, 1976·International Journal of Dermatology·V S Constantine
Dec 21, 2005·The Veterinary Clinics of North America. Small Animal Practice·Louis-Philippe de Lorimier
Jan 8, 2000·Dermatologic Clinics·M Duvic, J C Cather

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.